sb.scorecardresearch
Advertisement

Published 13:52 IST, February 9th 2024

Moderna-backed Metagenomi cuts US IPO valuation target to $563 mn

Moderna-backed Metagenomi cuts US IPO valuation target to $563 mn

Reported by: Business Desk
Follow: Google News Icon
  • share
Moderna-backed Metagenomi cuts US IPO valuation target to $563 mn
Moderna-backed Metagenomi cuts US IPO valuation target to $563 mn | Image: Metagenomi
  • Listen to this article
  • 1 min read
Advertisement

13:52 IST, February 9th 2024